Phase II Trial of Apixaban in Japanese Patients with Cancer-Associated Venous Thromboembolism

Trial Profile

Phase II Trial of Apixaban in Japanese Patients with Cancer-Associated Venous Thromboembolism

Recruiting
Phase of Trial: Phase II

Latest Information Update: 13 Mar 2018

At a glance

  • Drugs Apixaban (Primary)
  • Indications Venous thromboembolism
  • Focus Adverse reactions
  • Acronyms J-CAV study
  • Most Recent Events

    • 09 Mar 2018 Status changed from not yet recruiting to recruiting.
    • 05 Dec 2017 Planned initiation date changed from 9 Jan 2018 to 1 Feb 2018.
    • 13 Nov 2017 Planned initiation date changed from 1 Sep 2017 to 9 Jan 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top